Rishabh Jain, Medical Oncologist at AIIMS Delhi, shared on X:
“LAVA-CRLM: SBRT vs Microwave Ablation in colorectal liver metastases First prospective randomised Phase II trial directly comparing SBRT vs MWA in oligometastatic colorectal liver metastases.
100 patients randomised mITT population: 9 1-year freedom from local progression
Grade ≥2 treatment-related toxicity
- SBRT: 3%
- MWA: 25%
Grade ≥3 toxicity
- SBRT: 0%
- MWA: 8%1 treatment-related death with MWA
Take-home: No difference in local control was detected, but SBRT had a more favourable safety profile and offers a non-invasive local treatment option in appropriately selected patients. Phase II study, not powered to prove equivalence or non-inferiority.”
